Remove 2024 Remove Healthcare Remove Healthcare Provider Remove Networking
article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.

Retail 52
article thumbnail

How health plans can leverage competitive intelligence data today to drive impact in 2024

Clarify Health

The strategic use of competitive intelligence data is increasingly becoming a crucial factor for healthcare payers looking to make informed decisions around strategic market expansion and strengthen their market position.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Trends in Virtual Collaboration

Impetus Digital

With the end of the year quickly approaching, you will likely see multiple articles on the key trends of 2023 and predictions for 2024 start popping up. Some want to attend live meetings (whether web-based, hybrid, or in person) to be able to network “face-to-face.” Some physicians still prefer to communicate via emails.

article thumbnail

Five IDNs to watch in 2023

Clarivate

healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst. In a fiercely competitive U.S.

article thumbnail

Welldoc Receives 10th 510(k) Clearance from FDA for Award-Winning Diabetes Platform BlueStar®

Legacy MEDSearch

This enhanced functionality will be made available commercially in 2024. Insulin dosing is a critical piece to diabetes management, and now, Welldoc’s software has the power to deliver these important data and insights directly into the hands of adults living with diabetes, their caregivers and their healthcare providers.”

FDA 52
article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed. Medicines manufacturing is energy intensive.

article thumbnail

IndustryBRIEFS

PM360

Our acquisition of eSight is a strategic move to leverage this expertise in the healthcare industry to address the challenges of vision impairment, furthering our commitment to enhancing visual safety and quality of life.” The UK-based contingent now joins the Network in North America, sitting within the Havas New York Village.

Media 52